Deep Brain Stimulation Systems Market, By Application: (Parkinson's disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other), By Type: (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By End-user: (Hospitals, Ambulatory Surgical Centres, Neurological Clinics, Other End Users), By Region – Global Analysis Forecast Till 2030

The Global Deep Brain Stimulation Systems Market size was accounted for USD 1.10 billion in 2021 and is projected to grow at CAGR of 10.2% from 2022 to 2030

Deep Brain Stimulation (DBS) is a new surgical technique used to treat various neurological disorders. This includes battery-powered medical devices known as nerve stimulators. It sends electrical signals to specific parts of the brain that control movement and affective disorders such as mood, pain, weight, and arousal. This technique also helps deal with essential tremors, a common neuromotor disorder.

A DBS system consists of three components: A thin insulated wire called an electrode or lead that is placed in the brain. A nerve stimulator is placed under the skin, usually near the collarbone, to send out an electrical current and place another thin insulated wire called an extension wire that connects the leads to the nerve stimulator.

Market Dynamics:

Drivers:

Depression and stress linked to obesity are becoming more commonplace all around the world. The National Institute of Mental Health (NIHM) reported that 16 million American adults experienced at least one major depressive episode in 2012. Furthermore, the WHO estimates that more than 300 million persons globally experience depression. The therapeutic need for integrating long-term therapies such deep brain stimulators is increased by the prevalence of the condition and the high mortality rate. This substance has played a significant part in the development of treatments for depression. Therefore, it is anticipated that during the forecast period, the rising prevalence of these disorders would offer enormous growth potential.

Technological advancements in deep brain stimulators are expected to propel the growth of the deep brain stimulation systems market. These advances include robot-assisted implantation, improved microelectrode design, multi-target stimulation, integrated implantable pulse generators, MRI, and individualized directed programming. With these recent advances, deep brain stimulators have demonstrated greater efficacy and fewer side effects with greater symptomatic relief in patients with dyskinesia compared to conventional methods.

Restraints:

However, the implementation of certain government policies, such as the Affordable Care Act in the United States, and the risks associated with deep brain stimulation procedures will negatively impact the deep brain stimulation systems market.

Key players:

• Abbott (St. Jude Medical)

• Medtronic

• Boston Scientific Corporation

• Aleva Neurotherapeutics S.A.

• Nexstim

• LivaNova PLC

• Neuropace Inc.

• Beijing PINS Medical Co. Ltd.

• Fisher Wallace

• Functional Neuromodulation Ltd.

• Renishaw PLC

• And Others

Market Segmentation:

Deep Brain Stimulation Systems Market, By Application:

• Parkinson's Disease,

• Essential Tremor

• Obsessive Compulsive Disorder

• Epilepsy

• Dystonia

• Other Applications

Deep Brain Stimulation Systems Market, By Type:

• Single-channel Deep Brain Stimulator

• Dual-channel Deep Brain Stimulator

Deep Brain Stimulation Systems Market, By End-user:

• Hospitals

• Ambulatory Surgical Centers

• Neurological Clinics

• Other End Users

Deep Brain Stimulation Systems Market, By Region:

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Russia

  • Italy

  • Rest of Europe

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Rest of Asia Pacific

• Latin America

  • Brazil

  • Mexico

  • Rest of Latin America

• Middle East & Africa

  • GCC

  • Israel

  • South Africa

  • Rest of Middle East & Africa

Regional Analysis:

North America dominated the deep brain stimulation systems market with a share of XX% in 2021 owing to increase in government funding and awareness-raising initiatives for Parkinson's disease (PD). For example, in 2015, the Parkinson's Foundation funded more than 40 research projects for PD. Additionally, increasing FDA approvals for deep brain stimulants for the treatment of PD are contributing to the deep brain stimulation systems market growth. For example, in October 2016 St. Jude Medical is approved by the US FDA as St. Approved for Jude Medical Infinity DBS and directional lead technology for use in the treatment of Parkinson's disease.

However, Asia Pacific is expected to significantly drive the deep brain stimulation systems market in the future from 2022 to 2030. This is attributed to the increasing prevalence of neurodegenerative diseases along with unmet demand for effective and long-term solutions. Increasing awareness of neurological disease treatment options and improving clinical development frameworks in emerging economies are expected to drive the deep brain stimulation systems market growth in this region. Additionally, high growth opportunities in developing countries such as Japan, China, and India are likely to contribute to the deep brain stimulation systems market growth. Additionally, the establishment of organizations such as the Asia Pacific Center for Neuromodulation (APCN), established to promote research and awareness of the associated benefits of deep brain stimulation, is expected to boost regional growth.

Scope of the Report:

User

Tab Content